Nevertheless, there is a large body of evidence that ACE inhibitors reduce morbidity and mortality, improve cardiac function, regress LV remodeling, and prolong life in patients with heart failure (HF), not only improving cardiac function and increasing survival but also lessening myocardial re-infarction [194]. The gene discussed is ACE; the disease is heart failure.